Melphalan and urinary estrogens

Anderson, J.M. and Grant, J.K. and Gettinby, G. (1979) Melphalan and urinary estrogens. British Journal of Cancer, 40 (2). pp. 314-315. ISSN 1532-1827

Abstract

A test of the concept of chemical suppression of ovarian function by cytotoxic drugs previously reported (Anderson et al., 1978, Br. J. Cancer, 37, 477) revealed no supportive evidence from follicular and luteal-phase measurements of plasma oestradiol (E2) in 6 premenopausal women prescribed repeated 5-day courses of melphalan after mastectomy for cancer. To circumvent the difficulties of frequent repeated blood sampling, 3 of these patients were studied in greater depth.

• Share and Export
  

  RDF+XMLBibTeXRIOXX2 XMLRDF+N-TriplesJSONDublin CoreAtomSimple MetadataReferMETSHTML CitationASCII CitationOpenURL ContextObjectEndNoteOpenURL ContextObject in SpanMODSMPEG-21 DIDLEP3 XMLData Cite XMLRIS (EndNote Online, Zotero, Ref manager, etc)RDF+N3Multiline CSV
• Item metadata

  Item type:	Article
  ID code:	17846
  Dates:	Date Event 1979 Published
  Keywords:	melphalan, urinary estrogens, mastectomy, Probabilities. Mathematical statistics, Neoplasms. Tumors. Oncology (including Cancer), Cancer Research, Oncology, SDG 3 - Good Health and Well-being
  Subjects:	Science > Mathematics > Probabilities. Mathematical statistics Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)
  Department:	Faculty of Science > Mathematics and Statistics Faculty of Engineering > Design, Manufacture and Engineering Management
  Depositing user:	Strathprints Administrator
  Date deposited:	06 May 2010 13:06
  Last modified:	31 Aug 2022 10:31
  Related URLs:	Publisher
  URI:	https://strathprints.strath.ac.uk/id/eprint/17846